Skip to content
Disclosery

PURA VIDA INVESTMENTS, LLC

Follow

13F filer, CIK 1590144, NEW YORK, NY

PURA VIDA INVESTMENTS, LLC reported $16,630,510 across 8 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001590144-25-000006

Period
2025-06-30
Reported value
$16.6M
Holdings
8
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CAInew+45,000$2.4M
OMadded+424,120$1.34M
ESTAadded+44,940$960K
NTRAadded+243,191$418K
MGXadded+687,743$283K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BBNXreduced-426,620-$1.07B
IMDXreduced-928,434-$142M
KMTSexited-40,000-$997K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001590144-25-000006, largest first. % of portfolio is the value over $16,630,510, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 429,120 shares; 2025Q2: 2,500 shares 2,500$6.25M37.57%-426,620Timeline
IMDXINSIGHT MOLECULAR DIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 495,345 shares; 2024Q4: 654,451 shares; 2025Q1: 947,134 shares; 2025Q2: 18,700 shares 18,700$2.86M17.2%-928,434Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 45,000 shares 45,000$2.4M14.45%newTimeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 191,939 shares; 2024Q4: 113,041 shares; 2025Q1: 45,000 shares; 2025Q2: 89,940 shares 89,940$1.92M11.56%+44,940Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: 429,120 shares 429,120$1.36M8.18%+424,120Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 450,517 shares; 2024Q4: 450,517 shares; 2025Q1: 450,517 shares; 2025Q2: 450,517 shares 450,517$1.02M6.15%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 43,500 shares; 2024Q4: 5,000 shares; 2025Q1: 2,500 shares; 2025Q2: 245,691 shares 245,691$422K2.54%+243,191Timeline
MGXMETAGENOMI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 270,618 shares; 2024Q4: 264,391 shares; 2025Q1: 264,391 shares; 2025Q2: 952,134 shares 952,134$391K2.35%+687,743Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
KMTSKESTRA MED TECHNOLOGIES LTD40,000$997Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001590144-25-000006 base2025-08-13acceptance time not in the bulk data set